ARV-based HIV prevention for women – where we are in 2014

Women continue to be at special risk for HIV acquisition due to a complex mix of biological, behavioural, structural, cultural and social factors, with unacceptable rates of new infection. Scientific advances over the past decade have highlighted the use of antiretroviral (ARV) drugs as pre-exposure...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastro, Timothy D, Sista, Nirupama, Abdool-Karim, Quarraisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Women and ARV-based prevention: opportunities and challenges
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164013/
https://www.ncbi.nlm.nih.gov/pubmed/25224614
http://dx.doi.org/10.7448/IAS.17.3.19154
_version_ 1782334899919781888
author Mastro, Timothy D
Sista, Nirupama
Abdool-Karim, Quarraisha
author_facet Mastro, Timothy D
Sista, Nirupama
Abdool-Karim, Quarraisha
author_sort Mastro, Timothy D
collection PubMed
description Women continue to be at special risk for HIV acquisition due to a complex mix of biological, behavioural, structural, cultural and social factors, with unacceptable rates of new infection. Scientific advances over the past decade have highlighted the use of antiretroviral (ARV) drugs as pre-exposure prophylaxis (PrEP) to prevent HIV acquisition (sexually, parenterally and vertically) and ARV treatment (ART) for HIV-positive patients to prevent onward transmission (treatment as prevention – TasP). This paper reviews the evidence base for PrEP and TasP, describes new products in development and the need to translate research findings into programmes with impact at the population level.
format Online
Article
Text
id pubmed-4164013
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-41640132014-09-22 ARV-based HIV prevention for women – where we are in 2014 Mastro, Timothy D Sista, Nirupama Abdool-Karim, Quarraisha J Int AIDS Soc Women and ARV-based prevention: opportunities and challenges Women continue to be at special risk for HIV acquisition due to a complex mix of biological, behavioural, structural, cultural and social factors, with unacceptable rates of new infection. Scientific advances over the past decade have highlighted the use of antiretroviral (ARV) drugs as pre-exposure prophylaxis (PrEP) to prevent HIV acquisition (sexually, parenterally and vertically) and ARV treatment (ART) for HIV-positive patients to prevent onward transmission (treatment as prevention – TasP). This paper reviews the evidence base for PrEP and TasP, describes new products in development and the need to translate research findings into programmes with impact at the population level. International AIDS Society 2014-09-08 /pmc/articles/PMC4164013/ /pubmed/25224614 http://dx.doi.org/10.7448/IAS.17.3.19154 Text en © 2014 Mastro TD et al; licensee International AIDS Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Women and ARV-based prevention: opportunities and challenges
Mastro, Timothy D
Sista, Nirupama
Abdool-Karim, Quarraisha
ARV-based HIV prevention for women – where we are in 2014
title ARV-based HIV prevention for women – where we are in 2014
title_full ARV-based HIV prevention for women – where we are in 2014
title_fullStr ARV-based HIV prevention for women – where we are in 2014
title_full_unstemmed ARV-based HIV prevention for women – where we are in 2014
title_short ARV-based HIV prevention for women – where we are in 2014
title_sort arv-based hiv prevention for women – where we are in 2014
topic Women and ARV-based prevention: opportunities and challenges
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164013/
https://www.ncbi.nlm.nih.gov/pubmed/25224614
http://dx.doi.org/10.7448/IAS.17.3.19154
work_keys_str_mv AT mastrotimothyd arvbasedhivpreventionforwomenwherewearein2014
AT sistanirupama arvbasedhivpreventionforwomenwherewearein2014
AT abdoolkarimquarraisha arvbasedhivpreventionforwomenwherewearein2014

Ejemplares similares